# Efficacy of Intravenous Iron Infusion in Gestational Iron Deficiency Anemia in Dubai, United Arab Emirates, During 2018–2019: A Retrospective Study

## TL;DR

This study examines how effective intravenous iron infusions are at improving anemia in pregnant women in Dubai, finding some improvement but not reaching ideal levels.

## Contribution

The study provides local evidence on IV iron infusion efficacy for gestational iron deficiency anemia in the UAE.

## Key findings

- IV iron infusion increased hemoglobin levels by an average of 1.4 g/dL in GIDA patients.
- Post-intervention hemoglobin levels (10.4 g/dL) remained below the recommended range of 12-16 g/dL.

## Abstract

Objective: The objective is to investigate the effectiveness of intravenous (IV) iron infusion in increasing hemoglobin levels in gestational iron deficiency anemia (GIDA) patients in a tertiary-care hospital in Dubai emirate, United Arab Emirates (UAE).

Methods: This is a retrospective cohort study of GIDA patients who were exposed to IV iron infusion supplementation. Study data of 40 cases aged 25-45 in a tertiary-care hospital in the UAE between 2018 and 2019 were analyzed. Variables accounted for were maternal age, age of gestation when IV iron was administered, and IV iron dose.

Results: The average hemoglobin level before the intervention was 9 g/dL, and the average change after the intervention was 10.4 g/dL with a mean of 1.4 g/dL difference between before and after the intervention.

Conclusion: Supplementation of IV iron infusion in GIDA patients was seen to have increased the hemoglobin level after the intervention; however, the increase did not meet the recommended range of 12-16 g/dL.